List of Excipients in API covid-19 vaccine, mrna
✉ Email this page to a colleague
Detailed excipient profiles for covid-19 vaccine, mrna
Excipient focus: ((4-HYDROXYBUTYL)AZANEDIYL)BIS(HEXANE-6,1-DIYL)BIS(2-HEXYLDECANOATE)
covid-19 vaccine, mrna drug variants containing ((4-HYDROXYBUTYL)AZANEDIYL)BIS(HEXANE-6,1-DIYL)BIS(2-HEXYLDECANOATE)
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | covid-19 vaccine, mrna | 0069-2025 |
| >Company | >Ingredient | >NDC |
covid-19 vaccine, mrna drug variants not containing ((4-HYDROXYBUTYL)AZANEDIYL)BIS(HEXANE-6,1-DIYL)BIS(2-HEXYLDECANOATE)
| Company | Ingredient | NDC |
|---|---|---|
| Moderna US Inc | covid-19 vaccine, mrna | 80777-100 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-102 |
| >Company | >Ingredient | >NDC |
Excipient focus: 1,2-DIMYRISTOYL-RAC-GLYCERO-3-METHOXYPOLYETHYLENE GLYCOL 2000
covid-19 vaccine, mrna drug variants containing 1,2-DIMYRISTOYL-RAC-GLYCERO-3-METHOXYPOLYETHYLENE GLYCOL 2000
| Company | Ingredient | NDC |
|---|---|---|
| Moderna US Inc | covid-19 vaccine, mrna | 80777-100 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-102 |
| >Company | >Ingredient | >NDC |
covid-19 vaccine, mrna drug variants not containing 1,2-DIMYRISTOYL-RAC-GLYCERO-3-METHOXYPOLYETHYLENE GLYCOL 2000
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | covid-19 vaccine, mrna | 0069-2025 |
| >Company | >Ingredient | >NDC |
Excipient focus: 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
covid-19 vaccine, mrna drug variants containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | covid-19 vaccine, mrna | 0069-2025 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-100 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-102 |
| >Company | >Ingredient | >NDC |
covid-19 vaccine, mrna drug variants not containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: 2-(MPEG 2000)-N,N-DITETRADECYLACETAMIDE
covid-19 vaccine, mrna drug variants containing 2-(MPEG 2000)-N,N-DITETRADECYLACETAMIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | covid-19 vaccine, mrna | 0069-2025 |
| >Company | >Ingredient | >NDC |
covid-19 vaccine, mrna drug variants not containing 2-(MPEG 2000)-N,N-DITETRADECYLACETAMIDE
| Company | Ingredient | NDC |
|---|---|---|
| Moderna US Inc | covid-19 vaccine, mrna | 80777-100 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-102 |
| >Company | >Ingredient | >NDC |
Excipient focus: ACETIC ACID
covid-19 vaccine, mrna drug variants containing ACETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Moderna US Inc | covid-19 vaccine, mrna | 80777-100 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-102 |
| >Company | >Ingredient | >NDC |
covid-19 vaccine, mrna drug variants not containing ACETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | covid-19 vaccine, mrna | 0069-2025 |
| >Company | >Ingredient | >NDC |
Excipient focus: CHOLESTEROL
covid-19 vaccine, mrna drug variants containing CHOLESTEROL
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | covid-19 vaccine, mrna | 0069-2025 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-100 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-102 |
| >Company | >Ingredient | >NDC |
covid-19 vaccine, mrna drug variants not containing CHOLESTEROL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SM-102
covid-19 vaccine, mrna drug variants containing SM-102
| Company | Ingredient | NDC |
|---|---|---|
| Moderna US Inc | covid-19 vaccine, mrna | 80777-100 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-102 |
| >Company | >Ingredient | >NDC |
covid-19 vaccine, mrna drug variants not containing SM-102
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | covid-19 vaccine, mrna | 0069-2025 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE
covid-19 vaccine, mrna drug variants containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Moderna US Inc | covid-19 vaccine, mrna | 80777-100 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-102 |
| >Company | >Ingredient | >NDC |
covid-19 vaccine, mrna drug variants not containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | covid-19 vaccine, mrna | 0069-2025 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
covid-19 vaccine, mrna drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | covid-19 vaccine, mrna | 0069-2025 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-100 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-102 |
| >Company | >Ingredient | >NDC |
covid-19 vaccine, mrna drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TROMETHAMINE
covid-19 vaccine, mrna drug variants containing TROMETHAMINE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | covid-19 vaccine, mrna | 0069-2025 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-100 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-102 |
| >Company | >Ingredient | >NDC |
covid-19 vaccine, mrna drug variants not containing TROMETHAMINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TROMETHAMINE HYDROCHLORIDE
covid-19 vaccine, mrna drug variants containing TROMETHAMINE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | covid-19 vaccine, mrna | 0069-2025 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-100 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-102 |
| >Company | >Ingredient | >NDC |
covid-19 vaccine, mrna drug variants not containing TROMETHAMINE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
covid-19 vaccine, mrna drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | covid-19 vaccine, mrna | 0069-2025 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-100 |
| Moderna US Inc | covid-19 vaccine, mrna | 80777-102 |
| >Company | >Ingredient | >NDC |
covid-19 vaccine, mrna drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
